ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 0308 • ACR Convergence 2023

    Burden of Osteoarthritis Attributable to High BMI in 38 OECD Countries: A Benchmarking Analysis

    Dhruvkumar Gadhiya1, Utsav Patel2, Hiren Chhayani3, Krushi Shah3, Sneh Patel3, Victor Adedara4, Divya Patel3 and Hardik Desai5, 1St.Luke's University Health, Anderson Campus, Easton, PA, 2Tulane University, New Orleans, LA, 3G.M.E.R.S. Medical College, Gandhinagar, Gandhinagar, India, 4St George’s University SOM, True Blue Greneda, True Blue, Grenada, 5Gujarat Adani Institute of Medical Sciences, Bhuj, India., Bhuj, India

    Background/Purpose: The burden of osteoarthritis related to high body mass index (BMI) in OECD countries is a significant public health concern. Osteoarthritis is strongly associated…
  • Abstract Number: 0324 • ACR Convergence 2023

    A Randomized, Double-blind, Placebo-controlled, Single Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection (IAI) of CNTX-4975-05 (CNTX) in Subjects with Chronic, Moderate-to-severe Osteoarthritis Knee Pain (OAKP) – Study 301

    Randall Stevens, James N Campbell, Colleen Newman and James Connolly, Centrexion Therapeutics Corporation, Boston, MA

    Background/Purpose: 30+ million US adults have OAKP. After years of using NSAIDs and other conservative measures many patients remain with OAKP. CNTX is a 1…
  • Abstract Number: 0865 • ACR Convergence 2023

    Reactive Oxygen Species-scavenging Nanoparticles Target Macrophage Polarization for Osteoarthritis Therapy

    Caifeng Deng1, Yongbing Xiao2, Xuan Zhao1, Hui Li2, Yuxiao Chen1, Chao Zeng2 and Guanghua Lei2, 1Xiangya Hospital, Changsha, China, 2Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China

    Background/Purpose: Unbalanced M1/M2 polarization of synovial macrophages plays vital roles in the symptomatic and structural progression of osteoarthritis (OA). The accumulation of intracellular reactive oxygen…
  • Abstract Number: 0882 • ACR Convergence 2023

    Activation of Ovarian Cancer G-Protein Coupled Receptor (OGR1) Attenuates Chondrocytes Inflammation via ERK1/2 Signaling Pathways in an in Vitro Model of Osteoarthritis

    Omar Syed, Bhakti Patel, William Martin, Martha Diaz-Hernandez, Hicham Drissi and Mohd Nazir Khan, Emory University, Atlanta, GA

    Background/Purpose: Osteoarthritis (OA) is the most prevalent joint disease, accounting for 50% of the musculoskeletal burden. Inflammation plays a crucial role in the development of…
  • Abstract Number: 1192 • ACR Convergence 2023

    Autoimmune Thyroid Disease Associates with Symptomatic Hand Osteoarthritis in Older Persons in the Third National Health and Nutrition Examination Survey

    Clement Tagoe1 and Wanyi Wang2, 1Albert Einstein College of Medicine, Bronx, NY, 2Elite Research, LLC, Irving, TX

    Background/Purpose: Osteoarthritis (OA) of the hand is associated with the presence of bony deformities in the proximal interphalangeal joints, distal interphalangeal joints, and first carpometacarpal…
  • Abstract Number: 1653 • ACR Convergence 2023

    Up or Down: Does Direction of Stair Climbing Difficulty Matter for Incident Functional Limitation and Knee Replacement in Knee Osteoarthritis?

    Jason Jakiela1, Thomas Bye1, Sydney Liles2 and Daniel White1, 1University of Delaware, Newark, DE, 2University of Delaware, Elkton, MD

    Background/Purpose: Knee osteoarthritis (OA) is a leading cause of functional limitation (FL) in older adults, with difficulty climbing stairs often the first-reported limitation. Overall increased…
  • Abstract Number: 1979 • ACR Convergence 2023

    Weight Loss Induced by Anti-obesity Medications and All-cause Mortality Among Patients with Knee or Hip Osteoarthritis

    Jie Wei1, david Hunter2, Nancy Lane3, Jing Wu4, Chao Zeng5, Guanghua Lei5 and Yuqing Zhang6, 1Health Management Center, Xiangya Hospital Central South University, Changsha, China, 2Sydney Musculoskeletal Health, University of Sydney, St. Leonards, Australia, 3University of California, Hillsborough, CA, 4Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, China, 5Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China, 6Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA

    Background/Purpose: The current international guidelines recommend weight loss for pain relief and functional improvement in overweight or obese patients with knee or hip osteoarthritis; however,…
  • Abstract Number: 1995 • ACR Convergence 2023

    Cross-cultural Adaptation, Reduction, and Validation of the Turkish Versions of the Flare-OA Questionnaire for Hip and Knee Osteoarthritis

    Mehmet Tuncay Duruöz1, Halise Hande Gezer1, Jonathan Epstein2, Marc Soudant2 and Francis Guillemin3, 1Marmara University Medical School PMR Department, Rheumatology Division, Istanbul, Turkey, 2Université de Lorraine, Epidémiologie clinique, Nancy, France, 3Université de Lorraine, EA 4360 Apemac, Nancy, France

    Background/Purpose: The Flare-OA is a recently developed self-reported questionnaire to assess the occurrence and severity of flares in knee and hip osteoarthritis (OA). It evaluates…
  • Abstract Number: 0309 • ACR Convergence 2023

    Efficacy, Safety, Pharmacokinetics and Immunogenicity of Repeated Dosing of GSK3858279 in Patients with Knee Osteoarthritis: A Phase I, Randomized, Double-Blind, Placebo-Controlled Study

    Jagtar Singh Nijjar1, Kathy Abbott-Banner2, Riju Ray3, Sam Munoz Vicente1, Jane H. Bentley1, Catherine Muya1, Sarah Siederer1, Eirini Panoilia1, Damon Bass4, Disala Fernando5 and Edward C. Emery1, 1GlaxoSmithKline, Stevenage, United Kingdom, 2GlaxoSmithKline, Brentford, United Kingdom, 3GSK Research, Triangle Park, 4GlaxoSmithKline, Upper Providence, RI, 5GlaxoSmithKline, Cambridge, United Kingdom

    Background/Purpose: Chronic pain is an unmet need in osteoarthritis (OA) as current therapies have limited analgesia and side effects. The chemokine CCL17 mediates inflammatory pain…
  • Abstract Number: 0481 • ACR Convergence 2023

    Automatically Detect Finger Joint Center and Angle on Hand X-ray: A Deep Learning Model

    Yuan Gao1, Juan Shan2, Raj Ponnusamy2, Jordan Blackadar3, Carmine Guida2, Jeffrey Driban4, Timothy McAlindon5 and Ming Zhang1, 1Boston University, Boston, MA, 2Pace University, New York, NY, 3Photo Diagnostic System, Boston, MA, 4Tufts Medical Center, Boston, MA, 5Tufts Medical Center, Arlington, MA

    Background/Purpose: Hand osteoarthritis (OA) is the second most common anatomic region for OA. The diagnosis and evaluation of hand OA heavily rely on subjective assessments…
  • Abstract Number: 0867 • ACR Convergence 2023

    Pentosan Polysulfate Sodium, a Glycosaminoglycan Mimetic Demonstrates Durable Effects on Pain, Function and Joint Structure in Canine Naturally Occurring Osteoarthritis

    Ravi Krishnan1, Catherine Stapledon2, Christian Reiter2, Stewart Ryan3, Sebastien Bauquier3 and Thierry Beths3, 1Paradigm Biopharmaceuticals, Adelaide, Australia, 2Paradigm Biopharmaceuticals, Melbourne, Australia, 3U-Vet Werribee Animal Hospital, University of Melbourne, Melbourne, Australia

    Background/Purpose: Pentosan Polysulfate sodium (PPS) is a semi-synthetic polysaccharide and a glycosaminoglycan mimetic. The multiple actions of PPS involve anti-inflammatory effects via inhibition of NF-κB;…
  • Abstract Number: 0883 • ACR Convergence 2023

    The Role of Plasmin and Fibrinolysis Pathways in Osteoarthritis

    Qian Wang, heidi Wong, Audrey Bai, Zelda Love, Constance Chu and William Robinson, Stanford School of Medicine, Stanford, CA

    Background/Purpose: Osteoarthritis (OA) is the major cause of joint failure. Increasing evidence suggests that activation of fibrinolysis is involved in the pathogenesis of OA. Here…
  • Abstract Number: 1193 • ACR Convergence 2023

    The Association of Peak Forces and Loading Rates During Walking with MRI-Based Structural Worsening of the Knee: The Multicenter Osteoarthritis Study

    Lauren Sara1, David Felson1, Michael LaValley2, Gabriela Rabasa1, Beth Lewis3, John Lynch4, Neil Segal5, Ali Guermazi1, Frank Roemer6, Joshua Stefanik7 and Cara Lewis1, 1Boston University, Boston, MA, 2Boston University School of Public Health, Arlington, MA, 3University of Alabama at Birimingham, Birmingham, AL, 4University of California San Francisco, San Francisco, CA, 5University of Kansas, Kansas City, KS, 6Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany, 7Northeastern University, Boston, MA

    Background/Purpose: Mechanical loading is an important, modifiable risk factor for knee osteoarthritis (OA). Walking loads have been previously proposed as a risk factor for developing…
  • Abstract Number: 1752 • ACR Convergence 2023

    Fibroblast Expression of Neurotransmitter Receptor HTR2A Associates with Inflammation in Rheumatoid Arthritis Joint

    Chunyan Xiang1, Soomin Hong1, Bingjiao Zhao2, Hui Pi3, Fang Du4, Xingyu Lu5, Yuanjia Tang1, Nan Shen6, Chunxi Yang7 and Runci Wang8, 1Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University (SJTUSM), Shanghai, China, 2Department of Orthodontics, Shanghai Stomatological Hospital & School of Stomatology, Fudan University, Shanghai, China, 3Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China, 4Department of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University (SJTUSM), Shanghai, China, 5Department of Endocrinology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 6Shanghai Jiao Tong University School of Medicine, Shanghai, China, 7Department of Orthopedics, Renji Hospital, School of Medicine, Shanghai Jiao Tong University (SJTUSM), Shanghai, China, 8Renji hospital, Shanghai Jiaotong University, Pudong Xinqu, China

    Background/Purpose: Peripheral neuroimmune crosstalk plays a crucial role in the inflammatory process and bone metabolism in joint. Serotonin receptor HTR2A was reported to be expressed…
  • Abstract Number: 1980 • ACR Convergence 2023

    Movement Evoked Pain as an Outcome Measure in Patients with Knee Osteoarthritis

    Leila Bagherzadeh1, Schnitzer Thomas2, Santiago Espinosa-Salas1 and Joana Barroso3, 1Northwestern Physical Medicine and Rehabilitation Department, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Anesthesiology; Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Pain, being one of the most crucial symptoms associated with knee OA, serves as a significant outcome measure for the increasing number of studies…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 71
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology